YopM and Plague

Conference paper

DOI: 10.1007/978-1-4614-3561-7_31

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 954)
Cite this paper as:
Straley S.C. (2012) YopM and Plague. In: de Almeida A., Leal N. (eds) Advances in Yersinia Research. Advances in Experimental Medicine and Biology, vol 954. Springer, New York, NY


YopM is required for full virulence of Yersinia pestis in systemic and bubonic plague, where it functions to counteract innate defenses. Our lab has been using the systemic plague model to identify the immunologic steps at which YopM has its earliest effects and then to work back to the associated signaling pathways affected by YopM. We have found that Gr1+ cells (polymorphonuclear leukocytes (PMNs), monocytes, and some dendritic cells (DCs)) are required to limit the growth of YopMY. pestis. Further, when mice lack the chemokine receptor CCR2, YopMY. pestis grows as well as the parent strain in both systemic and bubonic plague, indicating that YopM’s molecular targets ultimately act through CCR2. YopM disables the recruitment of CCR2+ Gr1+ inflammatory DCs into spleen, whereas in liver, it is the function of CCR2+ Gr1+ PMNs that is undermined. Microarray analysis of transcriptional differences in CD11b+ cells from spleens of mice infected with parent vs. YopMY. pestis points to the downregulation of expression of the transcription factor Egr-1 and of a chemokine ligand for CCR2, CCL2, as effects of YopM initiated by 1 h after infection. These findings provide a link between YopM’s effects at the molecular and immunological levels.

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  1. 1.Department of Microbiology, Immunology, and Molecular GeneticsUniversity of KentuckyLexingtonUSA

Personalised recommendations